LOGIN
Hip structural analysis of teriparatide vs placebo for postmenopausal osteoporotic women
October 2014
Hip structural analysis of teriparatide vs placebo for postmenopausal osteoporotic women
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
The effects of once-weekly teriparatide on hip geometry assessed by hip structural analysis in postmenopausal osteoporotic women with high fracture risk
Bone. 2014 Jul;64:75-81Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
209 postmenopausal osteoporotic women who were randomized in the TOWER trial in 2012 were analyzed to evaluate bone structural and strength changes at the hip after treatment with Teriparatide injection or placebo over 72 weeks. Patients were evaluated using hip structural analysis (HSA) based on dual-energy X-ray absorptiometry. The evidence presented in this trial demonstrated that Teriparatide ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.